MSF team pharmacy at Tibú, Colombia. Photo credit: Isabel Santiago Valenzuela/MSF
Letter |

CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir

Photo credit: Isabel Santiago Valenzuela/MSF

MSF Access Campaign signed onto this letter from over 120 civil society organisations and other signatories, in support of a resolution by Colombia's Ministry of Health proposing to issue a compulsory license for the key HIV medicine dolutegravir. A compulsory license would allow Colombia to make or import affordable generic dolutegravir for its HIV treatment needs, without requiring permission from the patent owner, ViiV Healthcare.

CSO letter supporting Resolution 881/23 by Colombia on issuing a compulsory license for HIV drug dolutegravir